China Compensates Family Of Child In Fatal Flu Vaccination
This article was originally published in PharmAsia News
Local authorities in China offered $5,115 in compensation to the parents of an infant who died after being given a vaccine made by Wosen Biotechnology. The company has begun its own investigation in the Shandong Province where a hospitalized child was injected with Wosen's vaccine against influenza B. The company and the family are divided on the need for an autopsy to learn the precise cause of death. Wosen said it sold more than 40,000 vaccines in China from the same batch linked with the death and does not know of any other side effects. The family is expected to sue Wosen if local authorities find quality issues with the firm's production process. (Click here for more
You may also be interested in...
Firm supplying all-in-one multivitamin blends rather than packs of multiple pills has four-member advisory board including digital marketing and consumer product marketing specialists and a health care strategist.
UK-headquartered company gets further backing from Novo Ventures and other investors convinced of the potential of NLRP3 inhibitors.
Mylan and Pfizer’s Upjohn have revealed a key date for their merger to create Viatris, after the deal set for midway through the year was pushed back recently due to the coronavirus pandemic.